Skip to main content

Peer Review reports

From: Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study

Original Submission
24 Sep 2018 Submitted Original manuscript
21 Nov 2018 Reviewed Reviewer Report - Arjun Nambiar
23 Jan 2019 Reviewed Reviewer Report - Kurt Naber
14 Feb 2019 Author responded Author comments - Derick Wade
Resubmission - Version 2
14 Feb 2019 Submitted Manuscript version 2
1 Mar 2019 Editorially accepted
16 Apr 2019 Article published 10.1186/s13063-019-3275-x

You can find further information about peer review here.

Back to article page